In addition, our previous genome-wide studies have shown that enhancers binding to the BAP1 complex are responsible for the recruitment of MLL3 COMPASS, which functions as a general tumor suppressor (Fig. 2C). This evidence concerns the gene BAP1 and neoplasm.